Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6831 USD | -5.52% | -14.84% | -51.55% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Financials (USD)
Sales 2024 * | 5.73M | Sales 2025 * | 16.48M | Capitalization | 34.88M |
---|---|---|---|---|---|
Net income 2024 * | -47M | Net income 2025 * | -42M | EV / Sales 2024 * | 6.08 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.12 x |
P/E ratio 2024 * |
-0.72
x | P/E ratio 2025 * |
-0.87
x | Employees | 70 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.61% |
Latest transcript on Lucid Diagnostics Inc.
1 day | -5.52% | ||
1 week | -14.84% | ||
Current month | -15.66% | ||
1 month | -35.56% | ||
3 months | -52.23% | ||
6 months | -46.63% | ||
Current year | -51.55% |
Managers | Title | Age | Since |
---|---|---|---|
Lishan Aklog
CEO | Chief Executive Officer | 58 | 18-05-07 |
Shaun O’Neil
PSD | President | 42 | 18-06-30 |
Dennis McGrath
DFI | Director of Finance/CFO | 67 | 18-05-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Cox
BRD | Director/Board Member | 81 | 18-05-07 |
Jacque Sokolov
BRD | Director/Board Member | 69 | 21-04-28 |
Stanley Lapidus
BRD | Director/Board Member | 75 | 21-07-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.6831 | -5.52% | 234 871 |
24-04-23 | 0.723 | -3.70% | 269,597 |
24-04-22 | 0.7508 | -5.74% | 173,753 |
24-04-19 | 0.7965 | -0.31% | 118,257 |
24-04-18 | 0.799 | -0.39% | 70,066 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.55% | 34.88M | |
+72.58% | 12.32B | |
-18.04% | 7.96B | |
+3.57% | 5.84B | |
+6.65% | 5.11B | |
+20.83% | 4.28B | |
-19.84% | 4B | |
-41.19% | 2.15B | |
+0.25% | 2.01B | |
+4.02% | 1.8B |
- Stock Market
- Equities
- LUCD Stock